| 1 |
Aurel M, Ali H, Albrecht G, et al. Patent foramen ovale (PFO): history, diagnosis, and management [J]. Cardiovasc Med, 2024, 25(11): 422.
|
| 2 |
Kheiwa A, Hari P, Madabhushi P, et al. Patent foramen ovale and atrial septal defect [J]. Echocardiography, 2020, 37(12): 2172-2184.
|
| 3 |
Das BB. Patent foramen ovale in fetal life, infancy and childhood [J]. Med Sci, 2020, 8(25): 456-468.
|
| 4 |
Miyawaki Y, Hitosugi M, Takeda A, et al. The characteristics and prevalence of patent foramen ovale in Japanese people: a study using material from forensic autopsies [J]. Biomedical Res, 2024, 45(3): 135-141.
|
| 5 |
Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts [J]. Mayo Clin Proc, 1984, 59(1): 17-20.
|
| 6 |
Meier B. A Cardiologist's perspective on patent foramen ovale-associated conditions [J]. Cardiology Clin, 2024, 42(4): 571-581.
|
| 7 |
Radico F, Foglietta M, Fulvio MD, et al. The 'dreaded PFO': anatomical and functional features of high risk for stroke [J]. Eur Heart J Suppl, 2021, 23(Suppl E): E189-E193.
|
| 8 |
Luca F, Pino PG, Parrini I, et al. Foramen ovale and cryptogenic stroke: integrated management [J]. J Clin Med, 2023, 12(5): 1914.
|
| 9 |
Immens MHM, van den Vincent V, van Lith Theresa J, et al. Heart-stroke team: a multidisciplinary assessment of patent foramen ovale-associated stroke [J]. Eur Stroke J, 2024, 9(1): 219-225.
|
| 10 |
Yildirim A, Aydin A, Demir T, et al. Echocardiographic follow-up of patent foramen ovale and the factors affecting spontaneous closure [J]. Acta Cardiol Sin, 2016, 32(6): 545-552.
|
| 11 |
Fordyce AM, Whalley GA, Coffey S, et al. Adjunct methods for the detection of patent foramen ovale: the contribution of transcranial Doppler and the Valsalva manoeuvre [J]. Heart Lung Circ, 2022, 31(11): 1471-1481.
|
| 12 |
Zhu Y, Zhang J, Huang B, et al. Impact of patent foramen ovale anatomic features on right-to-left shunt in patients with cryptogenic stroke [J]. Ultrasound Med Biol, 2021, 47(6): 1464-1472.
|
| 13 |
Chaturvedi A, Moroni F, Gertz MZ. Comparative evaluation of intracardiac, transesophageal, and transthoracic echocardiography in the assessment of patent foramen ovale: a retrospective single‐center study [J]. Catheter Cardiovasc Interv, 2023, 102(7): 1348-1356.
|
| 14 |
Zhou YY. Novel way of patent foramen ovale detection and percutaneous closure by intracardiac echocardiography: a case report [J]. World J Clin Cases, 2022, 10(29): 10559-10564.
|
| 15 |
Lee S, Kim IC, Kim YD, et al. The role of cardiac CT throughout the full cardiac cycle in diagnosing patent foramen ovale in patients with acute stroke [J]. Eur Radiol, 2021, 31(11): 7689-7700.
|
| 16 |
Sposato LA, Albin CS, Elkind MSV, et al. Patent foramen ovale management for secondary stroke prevention: state-of-the-art appraisal of current evidence [J]. Stroke, 2024, 55(1): 12-25.
|
| 17 |
Abdelghani M, El-Shedoudy SAO, Nassif M, et al. Management of patients with patent foramen ovale and cryptogenic stroke: an update [J]. Cardiology, 2019, 143(1-2): 68-79.
|
| 18 |
Wei D, Ju Y. Importance of an adequately performed Valsalva maneuver for detecting a right-to-left shunt indicating foramen ovale reopening [J]. J Ultrasound Med, 2015, 34(5): 879-883.
|
| 19 |
Caso V, Turc G, Abdul-Rahim A, et al. European Stroke Organisation (ESO) guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke [J]. Eur Stroke J, 2024, 9(3): 451-478.
|
| 20 |
Yan C, Li H. Preliminary investigation of in situ thrombus within patent foramen ovale in patients with and without stroke [J]. JAMA, 2021, 325(20): 2116-2118.
|
| 21 |
Wang XY, He L, Xie XG, et al. Thrombus inside the channel of patent foramen ovale revealed by optical coherence tomography imaging in a patient with myocardial infarction [J]. Eur Heart J Case Rep, 2024, 8(7): eytae304.
|
| 22 |
Turc G, Lee JY, Brochet E, et al. Atrial septal aneurysm, shunt size, and recurrent stroke risk in patients with patent foramen ovale [J]. J Am Coll Cardiol, 2020, 75(18): 2312-2320.
|
| 23 |
Nakashima M, Takaya Y, Nakayama R, et al. Morphological features of patent foramen ovale compared between older and young patients with cryptogenic ischemic stroke [J]. Circ J, 2024, 88(9): 1369-1376.
|
| 24 |
Kim BJ, Sohn H, Sun BJ, et al. Imaging characteristics of ischemic strokes related to patent foramen ovale [J]. Stroke, 2013, 44(12): 3350-3354.
|
| 25 |
张倩, 刘冉, 贺茂林. 伴卵圆孔未闭的隐源性脑梗死DWI影像学特征分析 [J/OL]. 中华脑血管病杂志(电子版), 2023, 17(2): 97-101.
|
| 26 |
陈彤, 樊东升. 卵圆孔未闭相关脑梗死的梗死模式及临床特点研究 [J/OL]. 中华脑血管病杂志(电子版), 2024, 18(1): 32-36.
|
| 27 |
Choi J, Kang MK, Jun JS, et al. Characteristics and prognosis of patients with cryptogenic stroke and suggestive of patent foramen ovale [J]. Cardiovasc Ultrasound, 2021, 19(1): 21.
|
| 28 |
Nagarajarao HS, Ojha CP, Kedar A, et al. Patent foramen ovale, the role of antiplatelet therapy alone or anticoagulant therapy alone versus device closure for cryptogenic stroke: a review of the literature and current recommendations [J]. Cardiovasc Hematol Agents Med Chem, 2020, 18(2): e20200212.
|
| 29 |
Kasner SE, Randall B, Andersen G, et al. Comparison of antiplatelet therapies for prevention of patent foramen ovale-associated stroke [J]. J Stroke Cerebrovasc Dis, 2020, 29(3): 104632.
|
| 30 |
Cannata F, Stankowski K, Donia D, et al. Percutaneous suture-based patent foramen ovale closure: a state-of-the-art review [J]. Trends Cardiovasc Med, 2024, 34(6): 404-413.
|
| 31 |
Voudris KV, Poulin MF, Kavinsky CJ. Updates on patent foramen ovale (PFO) closure [J]. Curr Cardiol Rep, 2024, 26(7): 735-746.
|
| 32 |
Mas JL, Geneviève D, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke [J]. N Engl J Med, 2017, 377(11): 1011-1021.
|
| 33 |
Mas JL, Derumeaux G, Guillon B, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke [J]. N Engl J Med, 2018, 378(11): 1083-1093.
|
| 34 |
Sondergaard L, Kasner SE, Rhodes JF, et al. Gore REDUCE study investigators. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke [J]. N Engl J Med, 2017, 377(11): 1033-1042.
|
| 35 |
Lee PH, Song JK, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial [J]. J Am Coll Cardiol, 2018, 71(20): 2335-2342.
|
| 36 |
Pristipino C, Sievert H, D'Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism [J]. Eur Heart J, 2019, 40(38): 3181-3197.
|
| 37 |
D'Andrea A, Dweck MR, Holte E, et al. EACVI survey on the management of patients with patent foramen ovale and cryptogenic stroke [J]. Eur Heart J Cardiovasc Imaging, 2021, 22(2): 167-175.
|
| 38 |
Anzai H, Child J, Natterson B, et al. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices [J]. Am J Cardiol, 2004, 94(4): 520-522.
|
| 39 |
Chessa M, Carminati M, Butera G, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect [J]. J Am Coll Cardiol, 2002, 39(6): 1061-1065.
|
| 40 |
Bédard E, Rodés-Cabau J, Houde C, et al. Enhanced thrombogenesis but not platelet activation is associated with transcatheter closure of patent foramen ovale in patients with cryptogenic stroke [J]. Stroke, 2007, 38(1): 100-104.
|
| 41 |
中华医学会心血管病学分会临床研究学组, 中华医学会神经病学分会脑血管病学组, 中国医师协会心血管内科医师分会结构性心脏病专业委员会. 卵圆孔未闭规范化诊疗中国专家共识 [J]. 中华心血管病杂志, 2024, 52(11): 1099-1110.
|
| 42 |
Khan F, Derbas LA, Messé SR, et al. Management of patients with patent foramen ovale and stroke: a national survey of interventional cardiologists and vascular neurologists [J]. J Am Heart Assoc, 2023, 12(13): e029451.
|
| 43 |
Collins N, Bhagwandeen R, Ekmejian A, et al. Multidisciplinary assessment in optimising results of percutaneous patent foramen ovale closure [J]. Heart Lung Circ, 2017, 26(Suppl 2): S14-S19.
|